MoonLake’s sonelokimab faces regulatory, commercial tests, RBC says
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Finance & Markets
Bessent warns Zelenskyy to 'be very careful' about claims U.S. is throttling Starlink
Starlink, high-speed satellite internet provided by Elon Musk's SpaceX, is critical to Ukraine's defense.
While consumers are angry about high-tech ways to set prices, a study of dynamic pricing found half the U.S. changes it recorded were decreases
“There are major tensions happening right now between who’s really going to have the power with some of these algorithms and usage of bots and AI: the companies or the shopper.”
The 10-Year Treasury Is Above 5% for the First Time in Almost 20 Years. History Says This Is How the S&P 500 Index Will Perform Over the Next 12 Months.
It's important to look at both the similarities and differences between the present and past.
Here's What $10,000 in Each of These 5 High-Yield Dividend Stocks Could Pay You in a Year
Key PointsSome of the best dividend stocks can be found in consumer staples, healthcare, energy, and REITs.
TSMC Is Spending up to $64 Billion This Year. Here's Why That's Great News for Investors.
Key PointsTSMC plans to spend $60 billion to $64 billion on new factories and equipment this year.
ICICI Bank (IBN) Q2 2027 Earnings Call Transcript
Profit surged 23.4% year-over-year as loan growth accelerated and asset quality improved.